Human Milk Oligosaccharides Market

Global Human Milk Oligosaccharides Market Size (2024 to 2029)

Global Human Milk Oligosaccharides Market size was worth US$ 236.3 million in 2024, and it is determined to reach a valuation of US$ 458.97 million by 2029, with a CAGR of 14.2%

It is structurally complex and diverse, making it difficult to extract or synthesize it for use in formulas. Because human milk oligosaccharides (HMOs) are beneficial for the microbial colony as a whole and for immunity, many key players are studying many new technologies, such as extracting HMO from cows, and executing expensive techniques (chemical or enzymatic synthesis) or producing them using microbes. And in development. they. Human milk oligosaccharide products (HMOs) are expensive because large amounts of human milk must be synthesized to obtain a small amount of HMO. Therefore, extraction and synthesis techniques are improving. The oligosaccharides in human milk are unconjugated complex carbohydrates that are found abundantly in human milk. It is the third most abundant component after fats and carbohydrates in breast milk. It acts as a probiotic that helps form symbiotic bacteria. It also acts as a release agent that helps prevent microbial pathogens from adhering to the mucosal surface. Helps reduce the risk of viral, bacterial and protozoal parasitic infections.

A key factor driving the growth of the global human milk oligosaccharides market is the rising awareness of their applications, health benefits, and technological advancements.

Global Human Milk Oligosaccharides Market Drivers:

The changing lifestyles of the younger and older population are encouraging people to lead a healthy lifestyle. To stay healthy, people prefer supplements to food to boost immunity for a longer, healthier life.

People also prefer it for children's use because of its potential benefits such as boosting immunity, good nutrition, and providing good bacteria in the gut. Therefore, these product characteristics are increasing the demand around the world. Increased knowledge of HMOs and the benefits of enhancing immunity and bacterial growth, essential for the human body, are driving the growth of the market. The growth of functional food applications and product lines is another factor driving demand for HMOs. Also, the growth of R&D for HMO mining with new technologies is also expected to drive market growth. The oligosaccharides in human milk are widely used in livestock feed to regulate the metabolism of animals and improve the digestive system. Therefore, the increasing demand for dairy products and supplements globally is a key factor that is expected to drive the growth of the global market for breast milk oligosaccharides during the foreseen period. Growing concerns about the gut health of people around the world and the increasing demand for dietary supplements are driving the growth of the target market due to the ability of oligosaccharides in human milk to function as soluble bait receptors and to prevent them from Microbial pathogens adhere to the epithelial surface. Lifestyle changes and increased health care spending are expected to support the increasing consumption of various dietary supplements by people around the world and are supposed to further the growth of the global milk oligosaccharide market maternal during the forecast period.

Growing consumer concerns for gut health and increased consumption of dietary supplements are expected to drive growth. Human milk oligosaccharides strengthen the immune system and also improve the gut microbiota when used in adult nutrition as it functional foods and supplements. Adding HMO to functional foods and beverages can promote the growth of good bacteria and kill harmful bacteria like Salmonella and Campylobacter. These factors are expected to drive market development during the forecast period. The ability of breast milk to protect babies from infections and allergic reactions will determine the size of the market. In addition, this compound drives market trends by inhibiting the adhesion of intestinal microflora, the proliferation of pathogens and organic acids, and reducing inflammation. This product helps maintain intestinal health by increasing the production of short-chain fatty acids, which are the key energy sources of intestinal cells and key molecules for maintaining intestinal health. The growth of the breast milk oligosaccharide market is highlighted by a number of factors. The growing demand for infant formulas, the growing demand for food supplements, the promising growth of the dairy industry, and health awareness are key factors driving the market.

Global Human Milk Oligosaccharides Market Restraints:

The high cost of production has been identified as a major limitation in the market for breast milk oligosaccharides. Due to the low availability of the donor pool, it cannot be synthesized directly from breast milk. Several manufacturers are working to develop technologies to produce products through synthetic and enzymatic methods. However, synthetic and enzymatic methods are a great threat to market growth as they require large resources and capital to produce the final product. Lack of technology for large-scale production, high R&D costs, and strict government regulations are likely to limit the growth of the HMO market.

REPORT COVERAGE: 

This research report on the Global Human Milk Oligosaccharides Market has been segmented and sub-segmented based on product, application, and region. 

Global Human Milk Oligosaccharides Market – By Product:

Depending on the type of product, the market is divided into

• 3'-fucosillactose (3'FL)
• 2'-fucosillactose
• lacto-n-tetraose (LNT)
• 6'-sialylactose (6'SL)
• 3'-sialylactose (3 ' SL)
• LNnT (lacto-n-neotetraose)

The Lacto-N-neotetraose segment had a significant share in 2020. This is because it increased the growth of beneficial bifidobacteria and reduced the growth of pathogenic bacteria. These are customers who are supposed to drive the growth of the human milk oligosaccharide (HMO) market. The 2'-fucosyl lactose product type is expected to take the dominant market share for its anti-infective properties. This can also be attributed to the fact that it has a positive effect on the nervous system and cognition and reduces the risk of inflammation in the baby.

Global Human Milk Oligosaccharides Market – By Application:

By application, the market for human milk oligosaccharides is segmented into

• food supplements
• infant formulas
• functional foods and beverages

Global Human Milk Oligosaccharides Market – By Region:

• North America
• Europe
• The Asia Pacific
• Latin America 
• The Middle East and Africa

KEY MARKET PLAYERS:

Key Market Players of Human Milk Oligosaccharides Market are ZuChem Inc, Medolac Laboratories, Glycom, Elicityl SA, Inbiose NV, Glycosyn LLC, Dextra Group, Jennewein Biotechnologie GmbH, DowDuPont Inc, GNUbiotics Sciences, ProZyme Inc.

RECENT HAPPENINGS IN THE MARKET:

• In May 2019, Glycosyn LLC and BASF SE signed an agreement for the development and commercialization of HMOs widely used in dietary supplements, functional nutrition and medical foods.
• In September 2020, Jennewein Biotechnologie GmbH was awarded Chr. Hansen Holding A / S, a leading life sciences company based in Hoersholm / Denmark, leads the global market for human milk oligosaccharides (HMO).